Home Fairfield Boehringer Ingelheim appoints Yew Looi Liew as U.S. Human Pharma president

Boehringer Ingelheim appoints Yew Looi Liew as U.S. Human Pharma president

Liew, who succeeds Jean-Michel Boers, will be responsible for developing BI’s current human pharma portfolio and preparing the organization for future launches.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.